Heidelberg, Germany – June 28, 2018 – Novaliq GmbH, a specialty pharmaceutical company with the first water-free technology platform that transforms poorly soluble drugs into effective [...]
June 26, 2018 – We are delighted that Novaliq was selected as one of only four companies to present in OCTANe’s LaunchPad session during the Ophthalmology Technology Summit taking place in [...]
June 5, 2018 – Gerard Garhöfer, MD, and colleagues reported in a randomized study, that NovaTears has the ability to restore the tear film over time, due to the novel mode of action – [...]
June 4, 2018 – Gerard Garhöfer, MD, and colleagues reported in a randomized study, that NovaTears has the ability to restore the tear film over time, due to the novel mode of action – [...]
May 7, 2018 – At ARVO 2018, Gerhard Garhöfer, MD, discusses our clinical NT-004 study investigating the effect of NovaTears® on tear film thickness in dry eye patients:
Heidelberg, Germany – April 24, 2018 – Novaliq GmbH, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics [...]
April 16, 2018 – During OIS@ASCRS2018 in Washington, D.C., Bernhard Günther gave an interview with Healio/OSN about Novaliq Inc.’s clinical and business progress to date. Mr. Günther shared his [...]
March 19, 2018 –Christian Roesky, PhD, CEO and managing director of Novaliq GmbH, explains how the company’s water-free ophthalmic therapies can bring new treatments to ophthalmology’s most [...]
Heidelberg, Germany – January 8, 2018 – Novaliq GmbH, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics [...]
Heidelberg, Germany – January 8, 2018 – Novaliq GmbH, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics [...]
Novaliq uses cookies which are necessary for the proper functioning of its website. We may also use cookies to remember session management, to collect statistics, and to optimize site functionality. Click Agree and proceed to accept cookies and go directly to the site.
Decide which cookies you want to allow.
You can change these settings at any time. However, this can result in some functions no longer being available. For information on deleting the cookies, please consult your browser’s help function.
Learn more about the cookies we use.
